Skip to main content
. 2020 Oct 6;19:167. doi: 10.1186/s12933-020-01142-0

Fig. 2.

Fig. 2

Kaplan–Meier analysis according to different diabetic status (a), different PCSK9 levels (b), and status of both PCSK9 levels and diabetic status (c). PCSK9 proprotein convertase subtilisin/kexin type 9, non-DM non-diabetes mellitus, DM diabetes mellitus